Clinical Trial Update: Addition of Ondansetron to Ongoing Antipsychotic Treatment for Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 trial update examining whether adding ondansetron to ongoing antipsychotic therapy improves outcomes in schizophrenia; study completed with posted resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Ondansetron (ondansetron)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2021-08-13